Skip to main content
Earnings Labs
Acumen Pharmaceuticals, Inc. logo

Acumen Pharmaceuticals, Inc. (ABOS)

NASDAQ·Healthcare·Biotechnology

$0.22

-0.54%

Mkt Cap $15.20M

Analyst Ratings

Buy

3

Hold

1

Sell

0

Price Target (1 analysts)

$7.00

Range $7.00 – $7.00

Implied Upside

+3050.3%

Consensus $7.00 vs current $0.22